相关实验视频

Updated: Sep 18, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

射频废除和免疫疗法:为改善肝细胞癌控制策划免疫微环境

Liu Yang¹, Shuhang Wei¹, Zongxin Liu¹

¹Department of Gastroenterology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China.

|June 26, 2025

概括

通过将其与免疫疗法相结合,可以改善肝癌 (HCC) 的射频除 (RFA). 这种方法可以增强抗瘤免疫力,以向剩余的癌细胞并减少复发.

科学领域:

肝细胞癌研究肝细胞癌研究
免疫治疗是一种免疫疗法.
瘤微环境调制瘤微环境调制

背景情况:

射频除 (RFA) 是早期肝细胞癌 (HCC) 的主要治疗方法.
RFA影响肝脏瘤免疫微环境 (TIME),可能增强抗瘤免疫力.
不完整的RFA (IRFA) 可以产生免疫抑制的时间,促进瘤复发和转移.

研究的目的:

审查RFA如何调节HCC中的TIME.
探索 IRFA 后瘤细胞存活和入侵的免疫机制.
总结RFA和免疫治疗对TIME的联合影响以及HCC治疗的临床影响.

主要方法:

在HCC中对RFA和免疫治疗的文献综述.
在切除后的瘤微环境中分析免疫细胞动态.
综合关于联合治疗策略的当前研究.

主要成果:

RFA可以引起抗瘤免疫效应,但不完全除会导致免疫抑制.
免疫疗法激活了全身抗瘤反应.
将RFA与免疫疗法相结合可能会增强残留的HCC细胞的免疫向.

结论:

结合RFA和免疫疗法提供了一种有前途的策略,以改善HCC控制.
调节时间对于缓解RFA后复发至关重要.
这种结合方法为HCC治疗提供了新的见解.

关键词:

综合疗法综合疗法肝细胞癌是肝细胞癌.免疫疗法免疫疗法无线电频率剥离方式瘤免疫微环境是一个微环境.

更多相关视频

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

Thermal Ablation for the Treatment of Abdominal Tumors

Thermal Ablation for the Treatment of Abdominal Tumors

Published on: March 7, 2011

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...